Company Profile
Hangzhou CNRU Pharm&Chem Co.,Ltd is located in Hangzhou Northern Software Park，is specialized in the R&D, manufacture and sales of APIs and pharmaceutical intermediates，The company has a team of experienced and top-notch technicians and managers。The company can not only research and development of sublots new drug products, but also, and some companies have very good co-operation to meet the needs of customers from kilogram to tonnage level products 。
VIEW MORE VIEW LESSProduct List
| Product Name | Synonyms | CAS No. | Grate/Content | Operate |
|---|---|---|---|---|
(1R,2S)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol |
3-Cyclopenten-1-ol,2-[(phenylmethoxy)methyl]-,(1R,2S)-;3-Cyclopenten-1-ol,2-[(phenylmethoxy)methyl]-,(1R-trans)-;(1R,2S)-2-[(Phenylmethoxy)methyl]-3-cyclopenten-1-ol |
188399-48-6 | Inquiry | |
(7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
(7a,17b)-7-(9-Bromononyl)-estra-1,3,5(10)-triene-3,17-diol 17-acetate;Estra-1,3,5(10)-triene-3,17-diol,7-(9-broMononyl)-,17-acetate,(7a,17b)-;(7R,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11, 12,13,14,15,16,17-decahydro;(7a,17b)-7-(9-BroMononyl)-estra-1,3,5(1)-triene-3,17-diol 17-acetate;(7R,8R,9S,13S,14S,17S)-7-(9-BroMononyl)-3-hydroxy-13-Methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-17-yl acetate;FULVESTRANT INTERMEDIATES--5(N-3);Fulvestrant Intermediates-5(N-3);(7R,8R,9S,13S,14S,17S)-7-(9-Bromononyl)-3-hydroxy-13-methyl-7,8,9,11,12,13,14,15,16,17-decahyd |
875573-66-3 | Inquiry | |
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)thio]nonyl]-estra-1,3,5(10)-triene-3,17-diol 17-acetate |
(7a,17b)-7-[9-[(4,4,5,5,5-Pentafluoropentyl)Thio]N |
875573-69-6 | Inquiry | |
(RS)-4'-Cyano-3-(4-fluorophenylsulfonyl)-2-methyl-3'-(trifluoromethyl)propionanilide |
1166228-30-3 | Inquiry | ||
1H-Benz[de]isoquinolin-1-one, 2-(1-azabicyclo[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-, monohydrochloride, [R-(R*,S*)]- |
1H-Benz[de]isoquinolin-1-one,2-(3R)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-,hydrochloride (1:1),(3aS)-;1H-Benz[de]isoquinolin-1-one,2-(1-azabicyclo[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-,monohydrochloride,[R-(R*,S*)]-;(3aS)-2-(3R)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one hydrochloride (1:1);RS 25233-197 |
135729-76-9 | Inquiry | |
1H-Benz[de]isoquinolin-1-one,2-(3S)-1- azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6- hexahydro-,monohydrochloride,(3aR)- |
(R,S)-Palonosetron Hydrochloride;(3aR)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-1H-benz[de]isoquinolin-1-one Hydrochloride;3aR-2S-Palonosetron hydrochloride;(R,S)-Palonosetron;(R)-2-((S)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-;(R)-2-((S)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride;(3aR)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one,hydrochloride;(R)-2-((1R,3S,4R)-Quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one hydrochloride |
135755-51-0 | Inquiry | |
2-Fluoro-4-desfluoro Bicalutamide |
Propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(2-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide |
1159977-36-2 | Inquiry | |
3,5-Bis(2-cyanoprop-2-yl)benzyl bromide |
1,3-Benzenediacetonitrile,5-(bromomethyl)-α1,α1,α3,α3-tetramethyl-;1,3-Benzenediacetonitrile,5-(bromomethyl)-α,α,α′,α′-tetramethyl-;5-(Bromomethyl)-α1,α1,α3,α3-tetramethyl-1,3-benzenediacetonitrile;3,5-Bis(2-cyanoprop-2-yl)benzyl bromide;3,5-Bis(1-cyano-1-methylethyl)benzyl bromide;2,2′-(5-(Bromomethyl)-1,3-phenylene)bis(2-methylpropanenitrile);2-[3-(Bromomethyl)-5-(2-cyanopropan-2-yl)phenyl]-2-methylpropanenitrile |
120511-84-4 | Inquiry | |
3,5-Bis(2-cyanoprop-2-yl)toluene |
1,3-Benzenediacetonitrile,α1,α1,α3,α3,5-pentamethyl-;1,3-Benzenediacetonitrile,α,α,α′,α′,5-pentamethyl-;α1,α1,α3,α3,5-Pentamethyl-1,3-benzenediacetonitrile;2,2′-(5-Methyl-1,3-phenylene)di(2-methylpropionitrile);3,5-Bis(2-cyanoprop-2-yl)toluene;3,5-Bis(2-cyano-2-methylethyl)toluene;2-[3-(Cyanodimethylmethyl)-5-methylphenyl]-2-methylpropionitrile;2,2′-(5-Methyl-1,3-phenylene)bis(2-methylpropanenitrile);2,2′-(5-methylbenzene-1,3-diyl)bis(2-methylpropanenitrile);2-[3-(2-Cyanopropan-2-yl)-5-methylphenyl]-2-methylpropanenitrile |
120511-72-0 | Inquiry | |
4,4',4''-Methylidenetrisbenzonitrile |
4-[bis(4-cyanophenyl)methyl]benzonitrile; |
113402-31-6 | Inquiry | |
4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile |
Benzonitrile,4-(1H-1,2,4-triazol-1-ylmethyl)-;4-(1H-1,2,4-Triazol-1-ylmethyl)benzonitrile;4-1-(1,2,4-Triazolyl)-methyl-benzonitrile;4-[(1H-1,2,4-Triazol-1-yl)methyl]benzonitrile;4-2[1-(1,2,4-Triazol-1-yl)methyl]benzonitrile;1-(4-Cyanobenzyl)-1,2,4-triazole;4-[(1,2,4-Triazol-1-yl)methyl]benzonitrile |
112809-25-3 | Inquiry | |
6,7-Bis-(2-methoxyethoxy)-4(3H)-quinazolinone |
4(3H)-Quinazolinone,6,7-bis(2-methoxyethoxy)-;4(1H)-Quinazolinone,6,7-bis(2-methoxyethoxy)-;6,7-Bis(2-methoxyethoxy)-4(3H)-quinazolinone;6,7-Di(2-methoxyethoxy)-3,4-dihydroquinazolin-4-one;6,7-Bis(2-methoxyethoxy)-3,4-dihydroquinazolin-4-one;6,7-Bis(2-methoxyethoxy)quinazolin-4(3H)-one;6,7-Bis(2-methoxyethoxy)-quinazoline-4(3H)-one |
179688-29-0 | Inquiry | |
Aprepitant |
3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-;3H-1,2,4-Triazol-3-one,5-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,[2R-[2α(R*),3α]]-;5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one;L 754030;MK 869;Aprepitant;MK 0869;Emend;ONO 7436;221350-96-5 |
170729-80-3 | Inquiry | |
Azasetron hydrochloride |
2H-1,4-Benzoxazine-8-carboxamide,N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-,hydrochloride (1:1);2H-1,4-Benzoxazine-8-carboxamide,N-1-azabicyclo[2.2.2]oct-3-yl-6-chloro-3,4-dihydro-4-methyl-3-oxo-,monohydrochloride;Y 25130;Azasetron hydrochloride;Serotone;(±)-6-Chloro-3,4-dihydro-4-methyl-3-oxo-N-(3-quinuclidinyl)-2H-1,4-benzoxazine-8-carboxamide hydrochloride;132004-84-3;141922-90-9 |
123040-16-4 | Inquiry | |
Bicalutamide |
Propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-;Propanamide,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-,(±)-;N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide;ICI 176334;Casodex;(±)-4′-Cyano-α,α,α-trifluoro-3-[(p-fluorophenyl)sulfonyl]-2-methyl-m-lactotoluidide;Bicalutamide;Cosudex;ZD 176334;Casode;151262-58-7 |
90357-06-5 | Inquiry | |
Carbonic acid 2,5-dioxo-1-pyrrolidinyl [(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl] ester |
253265-97-3 | Inquiry | ||
Deshydroxy Bicalutamide |
Deshydroxy Bicalutamide;N-[4-Cyano-3-(trifluoroMethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-MethylpropanaMide;BicalutaMide Deshydroxy IMpurity;Bicalutamide EP Impurity C;Bicalutamide impurity D;(RS)-N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl) sulfonyl]-2-methyl-propanamide |
906008-94-4 | Inquiry | |
Entecavir hydrate |
6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,hydrate (1:1);6H-Purin-6-one,2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-,monohydrate;Entecavir monohydrate |
209216-23-9 | Inquiry | |
Erlotinib hydrochloride |
4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,hydrochloride (1:1);4-Quinazolinamine,N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-,monohydrochloride;CP 358774;OSI 774;Tarceva;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;[6,7-Bis(2-methoxyethoxy)quinazolin-4-yl]-(3-ethynylphenyl)amine hydrochloride;Erlotinib hydrochloride |
183319-69-9 | Inquiry | |
Fosaprepitant |
Phosphonic acid,P-[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-;Phosphonic acid,[3-[[2-[1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-,[2R-[2α(R*),3α]]-;Phosphonic acid,[3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]-;P-[3-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-2,5-dihydro-5-oxo-1H-1,2,4-triazol-1-yl]phosphonic acid;L 758298;Fosaprepitant;Ivemend |
172673-20-0 | Inquiry |
CONTACT INFORMATION
Sign In for Details